Literature DB >> 20381498

New insights into the molecular phenotype of eccentric hypertrophy.

Sebastiano Sciarretta, Junichi Sadoshima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20381498      PMCID： PMC2902863          DOI： 10.1016/j.yjmcc.2010.03.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  36 in total

1.  Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.

Authors:  Y Nagatomo; B A Carabello; M L Coker; P J McDermott; S Nemoto; M Hamawaki; F G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

2.  Regulation of cardiomyocyte mechanotransduction by the cardiac cycle.

Authors:  K Yamamoto; Q N Dang; Y Maeda; H Huang; R A Kelly; R T Lee
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

3.  Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart.

Authors:  F Wang; Y Seta; G Baumgarten; D J Engel; N Sivasubramanian; D L Mann
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes.

Authors:  R Aikawa; I Komuro; R Nagai; Y Yazaki
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Regulation of cardiac myocyte protein turnover and myofibrillar structure in vitro by specific directions of stretch.

Authors:  D G Simpson; M Majeski; T K Borg; L Terracio
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

6.  Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.

Authors:  T Kato; M Sano; S Miyoshi; T Sato; D Hakuno; H Ishida; H Kinoshita-Nakazawa; K Fukuda; S Ogawa
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

7.  Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

Authors:  R L Nicol; N Frey; G Pearson; M Cobb; J Richardson; E N Olson
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

8.  Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.

Authors:  Huanzhang Lu; Paul W M Fedak; Xiaojing Dai; Changqing Du; Yu-Qing Zhou; Mark Henkelman; Perry S Mongroo; Arthur Lau; Hideaki Yamabi; Aleksander Hinek; Mansoor Husain; Gregory Hannigan; John G Coles
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

9.  Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts.

Authors:  Naohiko Kobayashi; Shigeo Horinaka; Shin-ichiro Mita; Shigefumi Nakano; Takeaki Honda; Kohtaro Yoshida; Tsutomu Kobayashi; Hiroaki Matsuoka
Journal:  Cardiovasc Res       Date:  2002-09       Impact factor: 10.787

10.  Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.

Authors:  G G Serneri; M Boddi; I Cecioni; S Vanni; M Coppo; M L Papa; B Bandinelli; I Bertolozzi; G Polidori; T Toscano; M Maccherini; P A Modesti
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367
View more
  6 in total

Review 1.  Tissue-Engineering for the Study of Cardiac Biomechanics.

Authors:  Stephen P Ma; Gordana Vunjak-Novakovic
Journal:  J Biomech Eng       Date:  2016-02       Impact factor: 2.097

2.  Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.

Authors:  Karen A Ryall; Vassilios J Bezzerides; Anthony Rosenzweig; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2014-03-05       Impact factor: 5.000

3.  Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.

Authors:  Li-li Wang; Dori Miller; Desiree Wanders; Gayani Nanayakkara; Rajesh Amin; Robert Judd; Edward E Morrison; Ju-ming Zhong
Journal:  Acta Pharmacol Sin       Date:  2015-11-30       Impact factor: 6.150

4.  Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.

Authors:  Bradley S Ferguson; Brooke C Harrison; Mark Y Jeong; Brian G Reid; Michael F Wempe; Florence F Wagner; Edward B Holson; Timothy A McKinsey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

Review 5.  Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.

Authors:  Francesca Miceli; Vivianne Presta; Barbara Citoni; Flaminia Canichella; Ilaria Figliuzzi; Andrea Ferrucci; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-06       Impact factor: 3.738

6.  PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia.

Authors:  Nicholas Stafford; Min Zi; Florence Baudoin; Tamer M A Mohamed; Sukhpal Prehar; Daria De Giorgio; Elizabeth J Cartwright; Roberto Latini; Ludwig Neyses; Delvac Oceandy
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.